SCHEMBL21113463

SCHEMBL21113463

CCc1cn2c(N(C)C3CCN(CC(F)(F)F)CC3)c(C)c(C(=O)O)cc2c1-c1ccn[nH]1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EED O75530 1/20 0.35
RBBP4 Q09028 1/20 0.35
SUZ12 Q15022 1/20 0.35
EZH2 Q15910 1/20 0.35
AEBP2 Q6ZN18 1/20 0.35
CMA1 P23946 1/20 0.34
IDH1 O75874 1/20 0.34
LTA4H P09960 3/20 0.32
EIF4EBP1 Q13541 4/20 0.32
GUCY1A1 Q02108 1/20 0.31
GUCY1B1 Q02153 1/20 0.31
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
ABL1 P00519 1/20 0.31
HPGDS O60760 1/20 0.31
OPRM1 P35372 1/20 0.30
CALCRL Q16602 1/20 0.30
PTGER1 P34995 1/20 0.30
UBE2M P61081 1/20 0.30
DCUN1D1 Q96GG9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28958904 0.86 CMA1 (0.33) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964867 0.85 EED (0.45) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL28886599 0.70 EED (0.36) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964922 0.69 EZH2 (0.73) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21251371 0.67 EED (0.56) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964811 0.66 EED (0.66) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21113074 0.66 HPGDS (0.37) EZH2EIF4EBP1HPGDS
SCHEMBL19964731 0.65 EZH2 (0.36) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21157379 0.65 EZH2 (0.37) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL28958927 0.64 EED (0.37) EEDRBBP4SUZ12EZH2AEBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 EED 41/4885RBBP4 288/4885SUZ12 3/4885
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF EZH2, IKZF2, SUZ12 EED 41/4885RBBP4 288/4885SUZ12 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.